On this page · 5 sections→
Where the EU money came from
Funding by EU programme. Amounts are Valitacell Ltd's own share of each project, not the project's full budget.
- Horizon 2020€4.0M · 4 projects
Projects
4 EU-funded projects, newest first. Valitacell Ltd led 3 of them as coordinator. Each links to the official record.
- AutoCRATPartner
Automated Cellular Robot-Assisted Technologies for translation of discovery-led research in Osteoarthritis
Horizon 2020 · 2020–2024 · Project on CORDIS ↗
€744ktheir share - II-LCACoordinator
Integrated Imaging in live Cell Analysis (II-LCA), for enhanced development and manufacturing of biologic and cell therapies.
Horizon 2020 · 2019–2020 · Project on CORDIS ↗
€124ktheir share - iLCACoordinator
Intelligent Live Cell Analysis [iLCA] to transform disease management through faster, and more regulatory robust, discovery, manufacture and monitoring of biologic drugs & cell therapies
Horizon 2020 · 2019–2021 · Project on CORDIS ↗
€1.1Mtheir share - BIOSIMCoordinator
Accelerating the commercialisation of a disruptive analytical technology which enables the biopharmaceutical industry to manufacture drugs faster, cheaper and with greater regulatory confidence
Horizon 2020 · 2017–2019 · Project on CORDIS ↗
€2.0Mtheir share
Works most with
Organisations that shared the most EU projects with this one. A good starting list for consortium partners.
- Fraunhofer Gesellschaft zur Forderung der Angewandten Forschung eVGermany · 1 shared project
- Academisch Ziekenhuis LeidenNetherlands · 1 shared project
- Goeteborgs UniversitetSweden · 1 shared project
- University of GalwayIreland · 1 shared project
- Universita Degli Studi di GenovaItaly · 1 shared project
- Universitaetsklinikum EssenGermany · 1 shared project
- Pintail LtdIreland · 1 shared project
- Microcoat Biotechnologie GmbHGermany · 1 shared project
- Panaxea BVNetherlands · 1 shared project
- Solentim LtdUnited Kingdom · 1 shared project
Fields it works in
Research fields recorded on its Horizon projects.
- automation
- bioreactors
- cells technologies
- drug discovery
- economics
- gene therapy
- manufacturing engineering
- personalized medicine
- productivity
- software
- vaccines
Is this your organisation?
Claim it with an EUACC listing (€39 once, reviewed by our editors): add what you build, your team and what you are looking for. We pre-fill it from your EU records. Listed companies reach investors through our newsletter and get matched to new EU calls first.
Claim this profile →Source: CORDIS (Horizon Europe, Horizon 2020, FP7) and the EU Funding & Tenders Portal (other EU programmes), matched by the EU registration number (PIC). Past participation does not mean the organisation is open to new partnerships.